company background image
ACON logo

Aclarion NasdaqCM:ACON Stock Report

Last Price

US$0.33

Market Cap

US$2.3m

7D

-11.0%

1Y

-97.2%

Updated

27 Mar, 2024

Data

Company Financials +

ACON Stock Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.

ACON fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Aclarion, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aclarion
Historical stock prices
Current Share PriceUS$0.33
52 Week HighUS$37.92
52 Week LowUS$0.27
Beta0
1 Month Change-8.75%
3 Month Change-90.76%
1 Year Change-97.21%
3 Year Changen/a
5 Year Changen/a
Change since IPO-99.25%

Recent News & Updates

Recent updates

Shareholder Returns

ACONUS Healthcare ServicesUS Market
7D-11.0%0.04%0.4%
1Y-97.2%5.7%28.8%

Return vs Industry: ACON underperformed the US Healthcare Services industry which returned 5.8% over the past year.

Return vs Market: ACON underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is ACON's price volatile compared to industry and market?
ACON volatility
ACON Average Weekly Movement28.5%
Healthcare Services Industry Average Movement10.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: ACON's share price has been volatile over the past 3 months.

Volatility Over Time: ACON's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20075Brent Nesshttps://www.aclarion.com

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. Fundamentals Summary

How do Aclarion's earnings and revenue compare to its market cap?
ACON fundamental statistics
Market capUS$2.33m
Earnings (TTM)-US$4.91m
Revenue (TTM)US$75.40k

30.9x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACON income statement (TTM)
RevenueUS$75.40k
Cost of RevenueUS$75.73k
Gross Profit-US$324.00
Other ExpensesUS$4.91m
Earnings-US$4.91m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.69
Gross Margin-0.43%
Net Profit Margin-6,513.41%
Debt/Equity Ratio-154.6%

How did ACON perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.